文献速递基础与转化研究临床试验与 GCP组学、生物样本库与精准医学

肠道微生物组对哈斯卡普浆果健康效应的影响:随机对照试验研究方案

Impact of the gut microbiome on health impacts of Haskap berries: study protocol for a randomized control trial.
PubMed 文献 · Trials · 2026-05-05

本研究为四臂随机三盲安慰剂对照试验,纳入120名代谢健康与代谢不健康成人,每日饮用哈斯卡普或安慰剂果汁8周。主要结局包括血糖血脂炎症标志物、次极量运动脂肪氧化率、粪便16S rRNA微生物组成及粪便血清代谢组。旨在阐明肠道微生物组如何影响哈斯卡普浆果的代谢健康益处。

要点

  • 哈斯卡普浆果富含多酚,其健康效应可能由肠道微生物代谢介导。
  • 试验纳入代谢健康与不健康成人各60名,随机1:1接受哈斯卡普或安慰剂果汁8周。
  • 主要结局涵盖代谢、炎症、运动脂肪氧化、微生物组成及代谢组。

核心结论

  • 研究肠道微生物组对哈斯卡普浆果代谢健康益处的影响,有助于阐明其作用机制并为降低代谢疾病风险提供策略。

研究设计与样本

  • 四臂随机三盲安慰剂对照临床试验,纳入120名代谢健康与代谢不健康成人各60名,1:1随机每日饮用哈斯卡普或安慰剂果汁8周。

关键数值与推荐

  • 主要结局包括空腹血糖血脂代谢与炎症标志物、次极量运动脂肪氧化率、粪便16S rRNA微生物组成及质谱粪便血清代谢组数据。
  • 次要结局包括人体测量与睡眠质量指标及急性和习惯性膳食摄入数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Haskap berries have great potential as a superfood due to high polyphenolic content which confers both anti-inflammatory and antioxidant activity. These health impacts are mitigated, at least in part, by the gut microbiome as most ingested polyphenols pass to the large intestine for microbial enzymatic action and conversion to secondary phenolic metabolites. These microbial actions mediate both the bioavailability and the bioefficacy of Haskap-derived phenolics. However, clinical intervention trials characterizing the impact of long-term Haskap consumption on human health and the interaction between Haskap-derived phenolics and the gut microbiome are limited. This study aims to determine the impact of Haskap consumption on gut microbiome composition, gut microbial and serum metabolites, and other health outcome metrics in a cohort of adults with both low and high risk of metabolic syndrome. METHODS: This is a four-armed, randomized, triple-blind, placebo-controlled clinical trial conducted in a cohort of adults with both low and high risk of metabolic syndrome. A total of 120 participants (60 metabolically healthy, 60 metabolically unhealthy) will be randomized in a 1:1 ratio to consume a daily dose of either Haskap or placebo juice for 8 weeks. Outcome measures will be collected before and after the intervention period to determine the health impacts of Haskap in both groups. Primary outcome measures include fasting blood markers of glucose and lipid metabolism and inflammation, fat oxidation rates during submaximal exercise, 16S rRNA fecal microbial composition data, and mass spectrometry-acquired fecal and serum metabolomic data. Secondary outcome measures include anthropometric and sleep quality measures as well as acute and habitual dietary intake data. DISCUSSION: Investigating how the gut microbiome influences the health benefits of consuming Haskap berries will help elucidate potential mechanisms of Haskap-induced metabolic health benefits and help inform the development of effective strategies to decrease metabolic disease risk through Haskap consumption. TRIAL REGISTRATION: ClinicalTrials.gov NCT06546020. Registered on 1 August 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Chamberlin ML, Spears ML, Cooper G, et al. Impact of the gut microbiome on health impacts of Haskap berries: study protocol for a randomized control trial. Trials. 2026. PMID: 42087172. doi:10.1186/s13063-026-09759-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。